Now showing items 1-5 of 5
Malignancy in patients with sarcoidosis
(Ediciones Doyma, S.L., 2021)
The relationship between sarcoidosis and malignancy is not clear yet. We retrospectively evaluated 131 sarcoidosis patients followed-up at the single Rheumatology center. The incidence of malignancies was investigated in ...
Olaparib-related seronegative inflammatory arthritis: first report in the literature
(Taylor & Francis Ltd, 2021)
Cancer is among the most common causes of death worldwide. Recently, revolutionary targeted smart drugs have been used in the treatment of various malignancies. One of these intelligent molecules is PARP inhibitors, which ...
COVID-19 infection in a patient with FMF: does colchicine have a protective effect?
We read with great interest the report by Monti et al on the 320 rheumatic patients treated with various disease-modifying anti-rheumatic drugs (DMARDs) in the era of COVID-19 infection.1 They suggest that patients with ...
Tofacitinib-induced ramsay- hunt syndrome in a patient with rheumatoid arthritis
Background: Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by joint and systemic involvement. Tofacitinib is a JAK- inhibitor that is an effective agent in the treatment of active RA. Varicella ...
Ustekinumab-induced chronic lymphocytic leukemia in a patient with psoriatic arthritis
Abstract Psoriatic arthritis (PsA) is a chronic inflammatory disease characterized by skin and joint involvement. The disease may present with various joint pattern involvement, which sometimes may lead to joint destruction ...